Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine

J Headache Pain. 2021 Aug 26;22(1):100. doi: 10.1186/s10194-021-01307-6.
No abstract available

Publication types

  • Published Erratum